Welcome to our dedicated page for Leidos Holdings SEC filings (Ticker: LDOS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Leidos Holdings, Inc. filings document the regulatory record for a NYSE-listed government technology and mission-solutions contractor. The company’s reports and 8-K filings cover operating and financial results, segment reporting, material-event disclosures, capital-structure matters and NYSE common stock registration information.
Leidos filings also include proxy governance and shareholder voting materials, executive compensation disclosures, credit-facility agreements, acquisition disclosures and exhibits tied to press releases, financial statements and material agreements. These documents describe the company’s reporting structure, governance practices, financing arrangements and corporate transactions.
Leidos Holdings, Inc. director Robert S. Shapard reported a small compensation-related share award rather than an open-market trade. On June 30, 2026, he acquired 6.9569 shares of common stock at $0.0000 per share as dividend equivalent rights credited under a Key Executive Stock Deferral Plan, increasing that indirect plan holding to 1,631.9523 shares. He also reports 2,500 shares held indirectly through a family limited partnership and 60,027.0800 shares held directly.
KRAEMER HARRY M JANSEN JR reported acquisition or exercise transactions in this Form 4 filing.
Leidos Holdings, Inc. director Harry M. Jansen Kraemer Jr. reported an increase in his equity-based compensation. He was awarded 565.1218 shares of Common Stock as dividend equivalent rights credited at $0.00 per share to his account under the Key Executive Stock Deferral Plan, increasing his indirect ownership to 131,037.2887 shares. A separate holding entry shows he directly owns 93,281 shares of Leidos common stock after the reported date.
Leidos Holdings Sector President Roy E. Stevens reported routine equity compensation activity. He received 7.8032 shares of Leidos common stock at no cost as a grant/award classified as dividend equivalent rights under the Key Executive Stock Deferral Plan, held indirectly.
Following this award, his indirect holdings through the deferral plan total 1,805.414 common shares. A separate line in the filing reports 62,221 common shares held directly. The filing shows no open-market buying or selling activity, only a small, compensation-related acquisition.
Leidos Holdings, Inc. Chief Financial Officer Christopher R. Cage reported routine equity compensation activity. On June 30, 2026, an indirect acquisition of 113.2251 shares of Common Stock was credited at $0.00 per share under the Key Executive Stock Deferral Plan, described as dividend equivalent rights.
Following this grant, Cage’s indirect holdings through the plan totaled 31,840.4789 shares. A separate entry shows 64,829 shares of Common Stock held directly as a baseline position. The filing reports no open-market purchases or sales.
Antal Daniel J. reported acquisition or exercise transactions in this Form 4 filing.
Leidos Holdings, Inc. executive vice president and general counsel Daniel J. Antal reported updated holdings of company common stock. A Form 4 entry shows an award of 5.7491 shares of common stock credited at a price of $0.0000 per share as dividend equivalent rights under a Key Executive Stock Deferral Plan, held as indirect ownership. A separate holding line shows 14,241 shares of common stock held directly after the reported date.
Leidos Holdings director Gregory R. Dahlberg reported new equity awards. He received 1,067 shares of Leidos common stock on May 8, 2026 as a grant with no cash paid per share. After this award, he directly holds 24,036 common shares.
On the same date, he was also granted stock options for 1,281 shares of common stock at an exercise price of $131.2600 per share. According to the footnote, these options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual meeting of stockholders.
Leidos Holdings director David G. Fubini received new equity compensation. On May 8, 2026, he was granted 1,067 shares of common stock at no cost, increasing his direct holdings to 17,547.8435 shares. He was also awarded stock options for 1,281 shares at an exercise price of $131.26 per share.
The options relate to common stock and will vest and become exercisable in full on the earlier of the first anniversary of the grant date or the date the next annual meeting of stockholders is concluded. These Form 4 entries reflect compensation-related acquisitions rather than open-market purchases or sales.
Leidos Holdings, Inc. director Noel B. Geer reported new equity compensation awards. On 2026-05-08, Geer received a grant of 1,067 shares of Common Stock, bringing his directly held common stock to 44,273.8435 shares.
He was also granted stock options for 1,281 shares of Common Stock at an exercise price of $131.2600 per share, which vest in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholders’ meeting. In addition, indirect holdings include 32,000 shares held by a family trust and 2,000 shares held by his spouse.
Leidos Holdings, Inc. director Tina W. Jonas reported equity awards on Common Stock. She received 1,067 shares of Common Stock as a grant with no cash paid per share, increasing her direct holdings to 2,446 shares after the transaction.
She also received a stock option for 1,281 shares of Common Stock with an exercise price of $131.26 per share. The option vests and becomes exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholder meeting, and expires in 2033. Following this grant, she holds 1,281 stock options directly.
Leidos Holdings director Harry M. Jansen Kraemer Jr. reported new equity awards in the company. He received 1,067 shares of Common Stock indirectly through the Key Executive Stock Deferral Plan, recorded as an acquisition rather than an open-market purchase.
He was also granted 1,281 stock options with a $131.26 exercise price, each convertible into one share of common stock. According to the award terms, the option vests in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholders’ meeting.
Following these transactions, Kraemer holds 93,281 shares of Common Stock directly and 130,472.1669 shares indirectly through the deferral plan, along with the newly granted 1,281 stock options.